Head-to-head · The Verdict
Compare any two GLP-1 providers — on one honest scoreboard.
Every matchup is ruled on The Verdict Score — the same published six-factor rubric we apply to all 539 providers. Pick a head-to-head below, or find the best alternatives to the provider you're weighing.
#1 — Our top verdict
CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
The docket
Every ruling, with the dissent
CoreAge Rx against every other provider here. Where the losing side genuinely beats the winner on one of the six factors, we note it — a ruling that hides the dissent isn't worth much.
Docket No. 001
94 · 91
CoreAge Rx v. Eden
Majority ruling: CoreAge Rx prevails, A to A−.
Eden — FDA warning letter, June 2026. Addressed to Eden Health International Inc. dba Eden, and public in FDA’s warning-letter database.
Docket No. 002
94 · 87
CoreAge Rx v. Sesame Care
Majority ruling: CoreAge Rx prevails, A to B+.
Dissent: Sesame Care leads on Formulary choice (95 to 88).
Docket No. 003
94 · 87
CoreAge Rx v. ShedRx
Majority ruling: CoreAge Rx prevails, A to B+.
Dissent: ShedRx leads on Formulary choice (90 to 88).
Docket No. 004
94 · 89
CoreAge Rx v. Ondra Health
Majority ruling: CoreAge Rx prevails, A to B+.
Docket No. 005
94 · 86
CoreAge Rx v. Sprout Health
Majority ruling: CoreAge Rx prevails, A to B.
Sprout Health — FDA warning letter, September 2025. Addressed to Sprout Health Partners LLC dba Sprout Health, and public in FDA’s warning-letter database.
Docket No. 006
94 · 86
CoreAge Rx v. Gala Health
Majority ruling: CoreAge Rx prevails, A to B.
Docket No. 007
94 · 86
CoreAge Rx v. HealthRX
Majority ruling: CoreAge Rx prevails, A to B.
Dissent: HealthRX leads on Formulary choice (90 to 88).
Docket No. 008
94 · 86
CoreAge Rx v. RxSpan MD
Majority ruling: CoreAge Rx prevails, A to B.
Dissent: RxSpan MD leads on Formulary choice (90 to 88).
Docket No. 009
94 · 88
CoreAge Rx v. Vaylen
Majority ruling: CoreAge Rx prevails, A to B+.
Dissent: Vaylen leads on Formulary choice (91 to 88).
Docket No. 010
94 · 88
CoreAge Rx v. Invigor Medical
Majority ruling: CoreAge Rx prevails, A to B+.
Docket No. 011
94 · 85
CoreAge Rx v. Enhance MD
Majority ruling: CoreAge Rx prevails, A to B.
Docket No. 012
94 · 85
CoreAge Rx v. Telos Rx
Majority ruling: CoreAge Rx prevails, A to B.
Dissent: Telos Rx leads on Formulary choice (92 to 88).
Docket No. 013
94 · 87
CoreAge Rx v. Effecty
Majority ruling: CoreAge Rx prevails, A to B+.
Docket No. 014
94 · 87
CoreAge Rx v. Curex
Majority ruling: CoreAge Rx prevails, A to B+.
Curex — FDA warning letter, September 2025. Addressed to Curex, and public in FDA’s warning-letter database.
Docket No. 015
94 · 87
CoreAge Rx v. Ro
Majority ruling: CoreAge Rx prevails, A to B+.
Dissent: Ro leads on Formulary choice (92 to 88).
Popular head-to-heads
Top contenders, face to face
The matchups readers weigh most — our highest-ranked providers compared against each other.
Alternatives
Looking past one provider?
For any provider, see the top-rated alternatives we'd weigh against it — CoreAge Rx featured.
- Alternatives to CoreAge Rx
- Alternatives to Eden
- Alternatives to Sesame Care
- Alternatives to ShedRx
- Alternatives to Ondra Health
- Alternatives to Sprout Health
- Alternatives to Gala Health
- Alternatives to HealthRX
- Alternatives to RxSpan MD
- Alternatives to Vaylen
- Alternatives to Invigor Medical
- Alternatives to Enhance MD
- Alternatives to Telos Rx
- Alternatives to Effecty
- Alternatives to Curex
- Alternatives to Ro
- Alternatives to yourEra
- Alternatives to Strut Health
- Alternatives to MadeMed
- Alternatives to Precision Telemed
- Alternatives to BetterMe Rx
- Alternatives to AgelessRx
- Alternatives to bmiMD
- Alternatives to Trimi Health
Every comparison is ruled on The Verdict Score — our editorial judgment per the methodology. Assume any provider we list may compensate us — it never buys a higher score, and it never changes what a matchup says about either side. Not medical advice; see our disclosure.